National Health Investors plans $2.4M Schwab sale

Charles Schwab Corp. has filed a notice of proposed sale of its Common Stock under Form 144.

Rhea-AI Filing Summary

Charles Schwab Corp. has filed a notice of proposed sale of its Common Stock under Form 144. The filing lists common shares with an aggregate market value of $2,401,490.00 and a quantity of 49,110,434, with an approximate sale date of August 17, 2026 on the NYSE.

The notice also describes the historical sources of these securities, including multiple Restricted Stock Awards, Restricted Stock Options, an Open Market Purchase of 500 shares on February 22, 2018, and several small Dividend Reinvestment acquisitions dating back to 2016.

Key Figures

Aggregate market value of securities: $2,401,490.00 Quantity of securities listed: 49,110,434 Proposed sale date: 08/17/2026 +5 more

8 metrics

Aggregate market value of securities $2,401,490.00 Common Stock of Charles Schwab Corp. listed in the Form 144 notice

Quantity of securities listed 49,110,434 Units of Charles Schwab Corp. common stock covered by the Form 144

Proposed sale date 08/17/2026 Approximate date of sale for the Charles Schwab Corp. common stock

Restricted Stock Award shares (05/05/2025) 541 Shares from a Restricted Stock Award dated 05/05/2025

Restricted Stock Award shares (02/23/2025) 333 Shares from a Restricted Stock Award dated 02/23/2025

Restricted Stock Options shares (09/03/2024) 12,530 Shares tied to Restricted Stock Options dated 09/03/2024

Open Market Purchase shares 500 Common shares acquired via Open Market Purchase on 02/22/2018

Dividend Reinvestment shares (11/11/2016) 6 Common shares acquired through Dividend Reinvestment on 11/11/2016

Key Terms

Form 144, Restricted Stock Award, Restricted Stock Options, Open Market Purchase, +1 more

5 terms

Form 144 regulatory

"144: Securities Information Common Stock | Charles Schwab Corp."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Award financial

"Common | 05/05/2025 | Restricted Stock Award | Issuer"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Restricted Stock Options financial

"Common | 09/03/2024 | Restricted Stock Options | Issuer"

Open Market Purchase financial

"Common | 02/22/2018 | Open Market Purchase | Issuer"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Dividend Reinvestment financial

"Common | 05/11/2017 | Dividend Reinvestment | Issuer"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing related to NHI and Charles Schwab Corp. disclose?

The filing discloses a planned sale of Charles Schwab Corp. common stock with an aggregate market value of $2,401,490.00 and a listed quantity of 49,110,434 shares, to be sold on or after August 17, 2026 on the NYSE.

How many Charles Schwab Corp. shares are covered in this Form 144 notice?

The notice lists 49,110,434 units of Charles Schwab Corp. common stock. It also reports an aggregate market value of $2,401,490.00, tying the quantity to this dollar amount for the proposed NYSE sale around August 17, 2026.

What is the aggregate market value of the Charles Schwab stock in this Form 144?

The aggregate market value reported is $2,401,490.00. This value corresponds to the common stock units listed for potential sale, with trading expected on the NYSE and an approximate sale date of August 17, 2026.

When is the proposed sale date for the Charles Schwab Corp. shares in this Form 144?

The proposed sale date is listed as August 17, 2026. This date applies to the common stock covered by the notice, which has an aggregate market value of $2,401,490.00 and is intended for sale on the NYSE.

What types of awards and transactions generated the Charles Schwab shares in this Form 144?

The shares come from Restricted Stock Awards, Restricted Stock Options, an Open Market Purchase of 500 shares on February 22, 2018, and several small Dividend Reinvestment transactions from 2016 and 2017, all issued by Charles Schwab Corp.

Are recent sales of these Charles Schwab Corp. shares disclosed in the last 3 months?

The section labeled Securities Sold During The Past 3 Months is present, but no specific transactions are listed in the provided content, so only the planned sale and historical acquisition sources are detailed here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 11:16 AM Accepted by SEC EDGAR 08/17/2026 - 11:15 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001667637
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NATIONAL HEALTH INVESTORS INC
SEC File Number	001-10822
Address of Issuer	222 ROBERT ROSE DRIVE MURFREESBORO TENNESSEE 37129
Phone	6158909100
Name of Person for Whose Account the Securities are To Be Sold	Spaid John L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	33124	2401490.00	49110434	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/05/2025	Restricted Stock Award	Issuer			541	05/05/2025	N/A
Common	02/23/2025	Restricted Stock Award	Issuer			333	02/23/2025	N/A
Common	09/03/2024	Restricted Stock Options	Issuer			12530	09/03/2024	N/A
Common	08/23/2024	Restricted Stock Options	Issuer			7870	08/23/2024	N/A
Common	05/05/2024	Restricted Stock Award	Issuer			570	05/05/2024	N/A
Common	02/10/2020	Restricted Stock Options	Issuer			4795	02/10/2020	N/A
Common	01/30/2019	Restricted Stock Options	Issuer			5444	01/30/2019	N/A
Common	04/11/2016	Restricted Stock Options	Issuer			448	04/11/2016	N/A
Common	01/30/2019	Restricted Stock Options	Issuer			70	01/30/2019	N/A
Common	02/22/2018	Open Market Purchase	Issuer			500	02/22/2018	Cash
Common	05/11/2017	Dividend Reinvestment	Issuer			6	05/11/2017	Cash
Common	02/01/2017	Dividend Reinvestment	Issuer			6	02/01/2017	Cash
Common	11/11/2016	Dividend Reinvestment	Issuer			6	11/11/2016	Cash
Common	08/11/2016	Dividend Reinvestment	Issuer			5	08/11/2016	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The correct amount of shares being sold is actually 33,123.6372.
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	JOHN L SPAID
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)